June 1, 2017
JMA Vice President Toshio Nakagawa Members of the health ministry’s key drug pricing panel representing bill payers and healthcare providers both opposed the introduction of a so-called Japanese version of reference pricing systems that would reduce coverage for long-listed products...read more